<?xml version="1.0" encoding="UTF-8"?>
<ref id="bibr27-2515135520908121">
 <label>27</label>
 <mixed-citation publication-type="web">
  <collab>Medicago</collab>. 
  <article-title>Medicago announces phase 3 study of VLP quadrivalent influenza vaccine</article-title>, 
  <ext-link ext-link-type="uri" xlink:href="https://media.medicago.com/webfolder_download/951cb9f9114b2ed4e132b1c563ba870f/medicago-announces-phase-3-study-of-vlp-quadrivalent-influenza-vaccine/6936dd00ddfd77a354f293f8144269ffb22c029c/medicago-announces-phase-3-study-of-vlp-quadrivalent-influenza-vaccine.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">https://media.medicago.com/webfolder_download/951cb9f9114b2ed4e132b1c563ba870f/medicago-announces-phase-3-study-of-vlp-quadrivalent-influenza-vaccine/6936dd00ddfd77a354f293f8144269ffb22c029c/medicago-announces-phase-3-study-of-vlp-quadrivalent-influenza-vaccine.pdf</ext-link> (
  <year>2017</year>). (
  <comment>accessed 14 September 2018</comment>).
 </mixed-citation>
</ref>
